HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl-Heinz Storbeck Selected Research

11-ketodihydrotestosterone

9/2016High-throughput analysis of 19 endogenous androgenic steroids by ultra-performance convergence chromatography tandem mass spectrometry.
1/201611-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored.
6/201511β-Hydroxyandrostenedione: Downstream metabolism by 11βHSD, 17βHSD and SRD5A produces novel substrates in familiar pathways.
9/201311β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karl-Heinz Storbeck Research Topics

Disease

11Prostatic Neoplasms (Prostate Cancer)
01/2020 - 09/2013
4Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2021 - 09/2015
4Neoplasms (Cancer)
01/2020 - 09/2016
3Breast Neoplasms (Breast Cancer)
01/2021 - 09/2014
2Adrenocortical Carcinoma
01/2021 - 01/2016
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2017 - 09/2015
2Insulin Resistance
01/2017 - 02/2012
2Cardiovascular Diseases (Cardiovascular Disease)
03/2014 - 02/2012
1Addison Disease (Addison's Disease)
03/2021
1Infections
03/2021
1Hypoxia (Hypoxemia)
01/2020
1Feminization
10/2019
1Hyperplasia
12/2017
1Disease Progression
09/2016
1Carcinoma (Carcinomatosis)
02/2012
1Type 2 Diabetes Mellitus (MODY)
02/2012
1Metabolic Diseases (Metabolic Disease)
02/2012
1Hypertension (High Blood Pressure)
02/2012
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2012

Drug/Important Bio-Agent (IBA)

14AndrogensIBA
03/2021 - 09/2013
10SteroidsIBA
01/2020 - 02/2012
5Hormones (Hormone)IBA
01/2020 - 02/2012
411-ketodihydrotestosteroneIBA
09/2016 - 09/2013
3GlucocorticoidsIBA
01/2020 - 01/2017
3Androgen Receptors (Androgen Receptor)IBA
01/2018 - 09/2015
311-ketotestosteroneIBA
09/2016 - 11/2013
2Estrogens (Estrogen)FDA Link
01/2021 - 01/2018
2Testosterone (Sustanon)FDA Link
01/2020 - 09/2013
2adrenosteroneIBA
01/2017 - 11/2013
2Dihydrotestosterone (Androstanolone)IBA
01/2016 - 09/2013
2Progestins (Progestagens)IBA
01/2016 - 09/2014
1Aromatase (CYP19)IBA
01/2021
1Estrogen ReceptorsIBA
01/2021
1Ferredoxins (Ferredoxin)IBA
10/2019
1EnzymesIBA
01/2019
1enzalutamideIBA
01/2019
1abirateroneIBA
01/2019
1Aldo-Keto ReductasesIBA
10/2018
1ProgesteroneFDA LinkGeneric
01/2018
1Steroid 21-Hydroxylase (21 Hydroxylase)IBA
12/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Insulin (Novolin)FDA Link
01/2017
1LigandsIBA
09/2015
1Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
09/2014
1Norethindrone (Norethisterone)FDA LinkGeneric
09/2014
1Norethindrone Acetate (Norlutate)FDA LinkGeneric
09/2014
1CortisoneFDA Link
03/2014
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2014
1Oxidoreductases (Dehydrogenase)IBA
11/2013
1Dehydroepiandrosterone (DHEA)IBA
09/2013
1Androstenedione (4 Androstene 3,17 dione)IBA
09/2013
1aspalathinIBA
02/2012

Therapy/Procedure

7Castration
01/2020 - 09/2013
4Therapeutics
01/2020 - 09/2014